Richard A. Burkhart
Surgical Oncology
201 North Broadway Street, Viragh BLDG 5th FL
Viragh BLDG 5th FL
Baltimore, MD 21287
Viragh BLDG 5th FL
Baltimore, MD 21287
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 193 publications
Minimally Invasive Versus Open Surgery for Insulinoma: A 20-Year Institutional Experience.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: February 17, 2026
Improving Survival Models in Health Care by Balancing Imbalanced Cohorts: A Novel Approach.
Journal: JCO clinical cancer informatics
Published: January 28, 2026
Incidence of Endocrine and Exocrine Pancreatic Insufficiency after Minimally Invasive Parenchyma-Sparing Pancreatectomy.
Journal: Journal of the American College of Surgeons
Published: January 14, 2026
Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic multicenter development and validation of prognostic models.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: January 12, 2026
Prevalence and Imaging Characteristics of Chronic Calcific Pancreatitis in Patients With Newly Diagnosed Pancreatic Ductal Adenocarcinoma.
Journal: Journal of computer assisted tomography
Published: January 11, 2026
Indeterminate main pancreatic duct dilation: an endoscopic ultrasound-based machine learning model to distinguish main duct-intraductal papillary mucinous neoplasm from chronic pancreatitis.
Journal: Gastrointestinal endoscopy
Published: December 30, 2025
Value of Intraoperative Pancreatoscopy in Patients Undergoing Resection for Main-Duct Intraductal Papillary Mucinous Neoplasm: Thirty-Day Follow-Up of a Prospective International Study.
Journal: Annals of surgery open : perspectives of surgical history, education, and clinical approaches
Published: November 11, 2025
Safety and immunologic impact of neoadjuvant/adjuvant GVAX, cyclophosphamide, pembrolizumab, and anti-CSF1R agent IMC-CS4 in pancreatic adenocarcinoma.
Journal: Frontiers in immunology
Published: September 29, 2025
Response to 'Towards an individualized strategy in perioperative chemotherapy for pancreatic cancer'.
Journal: British journal of cancer
Published: September 22, 2025
Clinical, genomic, and spatial transcriptomic features of pancreatic adenosquamous carcinoma support subtype-specific therapeutic strategies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 01, 2025
Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individuals.
Journal: Gastro hep advances
Published: August 19, 2025
Outcomes of Hepatocellular Carcinoma involving the Portal Vein Main Trunk and/or the Inferior Vena Cava: Experience From a Multidisciplinary Liver Cancer Clinic.
Journal: Cancer medicine
Published: August 09, 2025
Last Updated: 09/26/2026